FACULTY
Lipid Based Cardiovascular Risk Reduction: Practical Strategies for Special Populations
Highlights from a Roundtable Symposium
Activity Date: October 2002  — Activity Info: Volume 2, (18)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

CHAIR

    Peter O. Kwiterovich, Jr, MD
    Professor of Medicine and Pediatrics
    Johns Hopkins University School of Medicine
    Director, Johns Hopkins University Lipid Clinic
    Chief, Lipid Research
    Johns Hopkins University Hospital
    Baltimore, Maryland
    • Dr Kwiterovich reports receiving grants and/or research support from AstraZeneca, Merck, Kos, and Pfizer; and serving as a consultant and receiving honoraria from Merck, Sankyo Pharma, and Kos.

PARTICIPATING FACULTY

    Theodore Feldman, MD
    Medical Director
    Miami Research Associates
    Coral Gables, Florida
    • Dr Feldman reports receiving grant and/or research support from Merck, Pfizer, Kos, Bristol-Myers Squibb, AstraZeneca, and GlaxoSmithKline; and serving as a consultant for Merck, Pfizer, Kos, and Sankyo.

    Mark Greathouse, MD
    Director, Program for the Prevention of Heart Disease
    West Penn Allegheny Health System
    Allegheny General Hospital
    Pittsburgh, Pennsylvania
    • Dr Greathouse reports serving as a consultant to and receiving honoraria from Bristol-Myers Squibb, Sanofi, Sankyo, and Merck; and receiving grant and/or research support from Bristol-Myers Squibb.

    James M. McKenney, PharmD
    Professor Emeritus
    Virginia Commonwealth University
    President and CEO
    National Clinical Research
    Richmond, Virginia
    • Dr McKenney reports receiving grant and/or research support from Kos, Sankyo, Bristol-Myers Squibb, Novartis, Pfizer, Merck, and AstraZeneca; serving as a consultant for Pfizer, AstraZeneca, and Sankyo; and receiving honoraria from Pfizer, Merck, AstraZeneca, and Reliant.

    Xue-Qiao Zhao, MD
    Assistant Professor of Medicine
    University of Washington Medical Center
    Cardiology Division
    Seattle, Washington
    • Dr Zhao reports receiving grant and/or research support from Merck, Pfizer, and AstraZeneca; serving as a consultant for Kos and Sankyo; and receiving honoraria from Merck, Pfizer, Kos, AstraZeneca, and Sankyo.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?